Panbela Therapeutics Insider ownership
What is the Insider ownership of Panbela Therapeutics?
The Insider ownership of Panbela Therapeutics Inc. is 14.55%
What is the definition of Insider ownership?
Insider Ownership is calculated as the total number of shares owned by insiders (shareholders who own more than 5% of the corporation or an officer or director of the company) divided by the total Shares Outstanding.
A high value of insider ownership means that those working for the company have a large stake in the success of the company. This is sometimes seen as a sign that those running the company will work hard to ensure its success or believe the company's stock price will rise.
A change in insider ownership may come from exercise of option, stock grant and buying or selling of company shares. A purchase of company share signifies a confidence in the company's future performance by people who know the company best. Therefore, Net Insider buying is also an important indicator for investors.
Insider ownership of companies in the Health Care sector on NASDAQ compared to Panbela Therapeutics
What does Panbela Therapeutics do?
Panbela Therapeutics, Inc., a clinical-stage biopharmaceutical company, together with its subsidiaries, focuses on developing disruptive therapeutics for the treatment of patients with cancer. The company focuses on diseases of the pancreas, including pancreatitis and pancreatic cancer, as well as neoadjuvant pancreatic cancer, colorectal cancer, ovarian cancer, and other agents in other cancer indications. Its lead product candidate is SBP-101, which is in Phase Ia/Ib clinical trial for the treatment of patients with metastatic pancreatic ductal adenocarcinoma. The company was formerly known as Sun BioPharma, Inc. and changed its name to Panbela Therapeutics, Inc. in December 2020. Panbela Therapeutics, Inc. was incorporated in 2011 and is based in Waconia, Minnesota.
Companies with insider ownership similar to Panbela Therapeutics
- Rimini Street has Insider ownership of 14.50%
- Casper Sleep Inc has Insider ownership of 14.50%
- Xali Gold Corp has Insider ownership of 14.50%
- Terra Tech has Insider ownership of 14.52%
- Sylla Gold Corp has Insider ownership of 14.52%
- Baron Oil Plc has Insider ownership of 14.53%
- Panbela Therapeutics has Insider ownership of 14.55%
- Allied Healthcare Product has Insider ownership of 14.55%
- Vikas WSP has Insider ownership of 14.56%
- United (Martins Ferry, OH) has Insider ownership of 14.58%
- Greenstone Capital has Insider ownership of 14.59%
- Longboat plc has Insider ownership of 14.59%
- United Security Bancshares (CA) has Insider ownership of 14.59%